U.S. Markets open in 5 hrs 15 mins

Meridian Bioscience, Inc. (VIVO)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
18.33+0.01 (+0.05%)
At close: 4:00PM EDT
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Premium required to access monthly data
Subscribe to Premium to download historical data
We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) 0.60
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 326.58
52 Week Low 35.51
50-Day Moving Average 317.17
200-Day Moving Average 317.53

Share Statistics

Avg Vol (3 month) 3662.13k
Avg Vol (10 day) 3385.22k
Shares Outstanding 542.86M
Float 39.36M
% Held by Insiders 11.17%
% Held by Institutions 187.16%
Shares Short (Sep 29, 2020) 42.92M
Short Ratio (Sep 29, 2020) 44.09
Short % of Float (Sep 29, 2020) 49.17%
Short % of Shares Outstanding (Sep 29, 2020) 46.81%
Shares Short (prior month Aug 30, 2020) 42.47M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Feb 13, 2019
Ex-Dividend Date 4Jan 31, 2019
Last Split Factor 23:2
Last Split Date 3May 13, 2007

Financial Highlights

Fiscal Year

Fiscal Year Ends Sep 29, 2019
Most Recent Quarter (mrq)Jun 29, 2020


Profit Margin 18.22%
Operating Margin (ttm)23.81%

Management Effectiveness

Return on Assets (ttm)9.64%
Return on Equity (ttm)20.76%

Income Statement

Revenue (ttm)240.36M
Revenue Per Share (ttm)5.62
Quarterly Revenue Growth (yoy)75.10%
Gross Profit (ttm)118.33M
Net Income Avi to Common (ttm)43.8M
Diluted EPS (ttm)1.02
Quarterly Earnings Growth (yoy)441.60%

Balance Sheet

Total Cash (mrq)63.45M
Total Cash Per Share (mrq)1.48
Total Debt (mrq)106.24M
Total Debt/Equity (mrq)45.53
Current Ratio (mrq)4.01
Book Value Per Share (mrq)5.45

Cash Flow Statement

Operating Cash Flow (ttm)38.99M
Levered Free Cash Flow (ttm)40.25M